Issued Patents 2025
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12338248 | Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors | Xiangzhu Wang, Wei He, Jie Su, Ke Liu, Jie Fan | 2025-06-24 |
| 12312316 | Compounds and methods for the targeted degradation of androgen receptor | Andrew P. Crew, Hanqing Dong, Xin Chen, Lawrence B. Snyder | 2025-05-27 |
| 12275716 | Modulators of estrogen receptor proteolysis and associated methods of use | Andrew P. Crew, Hanqing Dong, Keith R. Hornberger, Jing Wang, Craig M. Crews | 2025-04-15 |
| 12264157 | Compounds and methods for the enhanced degradation of targeted proteins | Andrew P. Crew, Craig M. Crews, Xin Chen, Hanqing Dong, Caterina Ferraro +6 more | 2025-04-01 |
| 12239711 | Cereblon ligands and bifunctional compounds comprising the same | Andrew P. Crew, Craig M. Crews, Hanqing Dong, Keith R. Hornberger, Lawrence B. Snyder +1 more | 2025-03-04 |
| 12208095 | Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders | Andrew P. Crew, John Flanagan, Sheryl Maxine GOUGH, Royal J. HASKELL, III, Marcia Dougan MOORE +2 more | 2025-01-28 |
| 12195459 | Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof | Robert Zhiyong Luo, Ji Liu, Pin Huang, Jie Su, Yan Feng +3 more | 2025-01-14 |